This article was originally published in The Gray Sheet
Executive SummaryHealth information systems and services provider Shared Medical Systems rejects a $2 bil. merger proposal from health care information solutions firm Eclipsys and remains "uninterested in a combination," SMS states March 3. The proposed merger, which would value SMS at $67 per share, represents a 75% premium over the stock's March 2 closing price of $38.25. The proposal "represents the most recent in a series of efforts" by Eclipsys Chairman Harvey Wilson "to cause SMS, in effect, to acquire his company, under circumstances in which he assumes management control," SMS explains. SMS recorded 1999 revenues of $1.2 bil. while Eclipsys had revenues of $249 mil
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.